Primary intestinal T-cell lymphoma and sclerosing cholangitis: A cytokine-mediated association?

Journal of Internal Medicine

Volumn 244, Issue 6, 1998, Pages 537-541

  Schattner, A ^a   Kozak, N ^a   Lassry, Y ^a   Sokolovskaya, N ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Cholestasis; Cytokines; Inflammatory bowel disease; Intestinal lymphoma; Primary clerosing cholangitis; T cell lymphoma

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DUODENUM BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; T CELL LYMPHOMA;

CHOLANGITIS, SCLEROSING; CYTOKINES; FEMALE; HUMANS; INTESTINAL NEOPLASMS; LYMPHOMA, T-CELL; MIDDLE AGED;

EID: 0031775004     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00434.x     Document Type: Article

References (26)

1. Chott A, Dragosics B, Radaszkiewicz T. Peripherla T-cell lymphomas of the intestine. Am J Pathol 1992; 141: 1361-71.
2. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994; 25: 1020-9.
3. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995 332: 924-33.
4. Brasitus TA. Protein losing enteropathy. In: Sleisenger MH, Fordtran JS. eds. Gastrointestinal Diseases, Vol. 1, 5th edn. Philadelphia: Saunders, 1993: 1027-35.
5. Strygler B, Nicar MJ, Santangelo WC, Porter JL, Fordtran JS. Alpha-1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterol 1990; 99: 1380-7.
6. Levison DA, Hall PA. Primary gut lymphomas. Leuk Lymphoma 1990; 2: 163-9.
7. Lerner A, Kumar V, Iancu TC. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin antireticulin and antiendomysial antibodies. Clin Exp Immunol 1994; 95: 78-82.
8. Carbonnel F, Lavergne A, Messing B, Tsapis A, Berger R, Galian A, Nemeth J, Brouet JC, Rambaud JC. Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation. Cancer 1994; 73: 1286-91.
9. Lindor KD, Wiesner RH, MacCarty RL, Ludwig J. Advances in primary sclerosing cholangitis. Am J Med 1990; 89: 73-80.
10. Ludwig J. Surgical pathology of the syndrome of primary sclerosing cholangitis. Am J Surg Pathol 1989; 13(Suppl 1): 43-9.
11. Mattila J, Aitola P, Matikainem M. Liver lesions found at colectomy in ulcerative colitis: correlation between histological findings and biochemical parameters. J Clin Pathol 1994; 47: 1019-21.
12. Olsson R, Hagerstrand I, Broome U, Danielsson A, Jarnerot G, Loof L, Prytz H, Ryden BO, Wallerstedt S. Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. J Clin Pathol 1995; 48: 933-5.
13. Broome U, Glaumann H, Hultcrantz R. Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests. Gut 1990; 31: 468-72.
14. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 1985; 102: 581-7.
15. Fausa O, Schrumpf E, Elgio K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991; II: 31-9.
16. Lindor KD, Wiesner RH, LaRusso NF, Homburger HA. Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitis. Hepatology 1987; 7: 884-8.
17. Chapman RW, Kelly PMA, Keryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988; 29: 422-7.
18. Bottazo GF, Pujol-Borrell R, Hanafusa T, Feldman M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; II: 1115-9.
19. Schattner A. Lymphokines in autoimmunity - a critical review. Clin Immunol Immunopathol 1994; 70: 177-89.
20. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101: 428-35.
21. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler-Anderson C, Bhan AK. Cytokine imbalance and autoantibody production in T cell receptor- mutant mice with inflammatory bowel disease. J Exp Med 1996; 183: 847-56.
22. Brandtzaeg P, Haraldsen G, Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 1997; 18: 555-89.
23. Altmeyer A, Dumant FJ. Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma. Cytokine 1993; 5: 133-43.
24. Burg G, Dummer R, Wilhelm M, Nestle F, Ott MM, Feller A, Hefner H, Lanz U, Schwinn A, Wiede J. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med 1991; 325: 1078-81.
25. Sarris AH, Esgleyes-Ribot T, Crow M, Broxmeyer HE, Karasavvas N, Pugh W, Grossman D, Deisseroth A, Duvic M. Cytokine loops involving interferon gamma and IP-10. a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood 1995; 86: 651-8.
26. Raziuddin S, Sheikha A, Abu-Eshy S, Al-Janadi M. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. Cancer 1994; 73: 2426-31.